{"name":"Attovia Therapeutics Inc","slug":"attovia-therapeutics-inc","ticker":"","exchange":"","domain":"attovia.com","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"Pharma / Biotech","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":2,"colorKey":"oncology","drugs":[{"name":"ATTO-1310","genericName":"ATTO-1310","slug":"atto-1310","indication":"Other","status":"phase_1"},{"name":"ATTO-3712","genericName":"ATTO-3712","slug":"atto-3712","indication":"Other","status":"phase_1"}]}],"pipeline":[{"name":"ATTO-1310","genericName":"ATTO-1310","slug":"atto-1310","phase":"phase_1","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"ATTO-3712","genericName":"ATTO-3712","slug":"atto-3712","phase":"phase_1","mechanism":"Small molecule","indications":[],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMingJBVV95cUxQdEFnQktFM210eXdiZmRhVlE4Y3FUTndfak5Cell5OFgyR1Z1QWxsaks4TzU0NTBvZlJIc0o3enpwWTlTYXBFR3o4eFZNZUg2QUpEZGN5Z3ZsTFRqTmZOMVBSZVpoa1YxT3ZHbFlaVVJOZHBWZjFkSE1jSFpXSVVpYVl2U1VhSHRJS1daVHZkSHAtLW5nbW1aeWZIZk9CQUxLNnVlYVF6VVZNRVdtT3ZpVzhMVkI1ODFPLUpqLWpBU3dEVnpWSldBX1JaTmZaX1VTUFJEc0hubWtXZGVwWmw4UmlyLUpTbk5MYVhCRENwaVByRVhzZXhobF9wUGJNYzUtMGNzWEFqbkN3enFKdFplVjJnYzVPQVduMDAzZ1Jn?oc=5","date":"2025-12-08","type":"regulatory","source":"GlobeNewswire","summary":"Eczema Clinical Trial Pipeline Accelerates as 100+ Pharma - GlobeNewswire","headline":"Eczema Clinical Trial Pipeline Accelerates as 100+ Pharma","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMinAFBVV95cUxPMnRqV04zT3ZWNm5jYWsyQ2pkNFBJUWJDdzZ5SzJBeUdoTUJuaGdZNU1DX0IxdjNmdnh5dlBZZG1sWDZnSUV3c3BRbUtXWjNGajJsbVBaSDB5VktmSk1wbE9aWF8zaDFpLU4tSVRGZ08xajdEb0ZySy0taFl0WGg3YUxpQm4tMTlsbTFJWlVNb1R5WXhzMGNLQUNSNGs?oc=5","date":"2025-04-15","type":"pipeline","source":"The Pharma Letter","summary":"Attovia Therapeutics closes $90 million Series C financing - The Pharma Letter","headline":"Attovia Therapeutics closes $90 million Series C financing","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiugFBVV95cUxQaEpqQUJjR1c3QmtCeVdkVjU3Q1ZkVmttQXVlRzdiXzhoWV9Fa0g4TF9QcC1CN2hBQ2R6OTF6amNRYzRyeW9xVjJZZFFCYzVrR0N2enQySHI5alZCVHhzSE13TjM4eTVCWjVjS0tGTVJPT0RyNFJLZ24yUXZlUFVCS29RQkVZcFFQMW9qazR4M0xrczRkX1lMQWtfdWdfUWNBUjA4Y2F3Y09TQWhiNERocXROVlRpSk9UVEE?oc=5","date":"2025-04-15","type":"earnings","source":"statnews.com","summary":"J&J reports earnings beat as tariffs loom - statnews.com","headline":"J&J reports earnings beat as tariffs loom","sentiment":"positive"},{"url":"https://news.google.com/rss/articles/CBMiqAJBVV95cUxPVHozdF84TXpnc1FXUl80WFlwZ3pDaVNTUDBaN0lpa1phdW5vcWZ1Q0VjWERrMTU4c0xHTzlWcmEtTElfZDd6UWcxRFlIZTBxc3JyRzNOZFYxa3ZrbnlWSmEwSUh2T3d2ell4Z29sazZVaGdubncwU0kyeTV3cmEzZ09GN3Bka1F6elhEeUlQNDVOVThjTnotckwxcExHenQ1R3Z2Wk5ZdWdoTUt3cDVPWVktbXVaUFhneXhhZEJGQ2JYM3NJZGFGZnBfTHFFZkRselo4WGtYZUd2UHNZSml6MGNHZGlmWmU3SXA5OXZINDY5YV94Z0t6TU5VYl9vOHY1V1pCOVhZUHJUcHZsdWpFVWhiNjNoczNZbnNoTE42WUdtd3M5NVFlYw?oc=5","date":"2025-04-15","type":"pipeline","source":"GlobeNewswire","summary":"Attovia Therapeutics Announces $90 Million Series C - GlobeNewswire","headline":"Attovia Therapeutics Announces $90 Million Series C","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMisAFBVV95cUxPMnhyN1RhSjdEazVQSUdSQmNrMkhIVGJyNXpGa0N1cmppZVdkRTJPUmplM1BUeU4xSjVDaUMtTzNvOGtkS2o0dzRGcm53VXh2aWR5VEw3djFJUHgyR1Awb3VHRU45aVdubXJtcm9GeDctVFZKUUZ2WjV2V1puczlfbUNDV0hFdUZwUlJKeEppWVhNMi1BMXZUdFFsX0VXaDhDUVRMQ2stM1AzYkhWX1VtYQ?oc=5","date":"2024-05-10","type":"regulatory","source":"The Business Journals","summary":"East Bay biotech raises $105 million, aims to enter clinical trials with eczema drug - The Business Journals","headline":"East Bay biotech raises $105 million, aims to enter clinical trials with eczema drug","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiiwJBVV95cUxObVBubkpRNHE0bmhuQjBPcm5NWGwwZnFwZ3EtZ2xCS2trNGNhdElSV09RZzAtWUZSUnQ4dDFmaWU0TGJfYVA5aXhtVDdMLWpRamxTTmdBNGlfVGNIWFNOWkxVa29aME9qRVpHVjMwckxXdVVMVmVMQmNLNDhJenl4UUd2MTJGUW1HenBOVDlHRF9wbW95OFdPS2NwNFctMEEycWtmaS13el8zaDNTTHFaSWpMMFlSYmZ0eVNhcFBTYmt5eFRVWGY4YzR2bm9wYVZuVTJtTV9LTFZnc3g2RnRBQVFzbTN4MURVMi1Yb3U0ak9TV0pldmVkR2tEbnp4OUN6VzNybWFJVjdKUzQ?oc=5","date":"2024-05-09","type":"pipeline","source":"GlobeNewswire","summary":"Attovia Therapeutics Raises $105 Million Oversubscribed Series B Financing Led by Goldman Sachs Alternatives - GlobeNewswire","headline":"Attovia Therapeutics Raises $105 Million Oversubscribed Series B Financing Led by Goldman Sachs Alternatives","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMib0FVX3lxTE1ta2pCMG5vZ1BZZXpkQkFsN0Z0WDJfYWphOXFrcHhiODVzNmcwdndwREFzUklad1J4Wk4zTzV2cVdMazBBVW1ORHB2cC1SdTdtU2hOeWZCeFg0cFlRS0tQT2Noc1gzbjNpZG5NUG5Wb9IBdEFVX3lxTE1fVXlYdzBzRTV5eTJSNk8xM1NFMXd1SnBzZUI4UGRjVGVhYnVNRVVaR3duQ3VDTDFPbkFGSEhPVjVZU1dLNWUtd3hEamdfN1puY0wzRjFCcW5Ld1JBWFBmZzdzNmxaNzh0bmNKOTFfMzBKenh1?oc=5","date":"2023-07-11","type":"pipeline","source":"Pulse 2.0","summary":"Attovia Therapeutics: Precision Proteomics Company Closes $60 Million In Funding - Pulse 2.0","headline":"Attovia Therapeutics: Precision Proteomics Company Closes $60 Million In Funding - Pulse 2.0","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiiAFBVV95cUxQakt6UGlxbDQyQWNJaGphc1paRlpfTFNjVWRGTTZocFlBUTE4RV8taEVoS3lxT1BNTHNhcTNHMjdleVpzWnNObUFhbmp1VlZaampfZmpYeU41ZmNaZFQ1cngyODVnOTA1d1E2R0Rvd0xYeXFMd0dVM2d1cFFDczBzTlBsQUcwclB1?oc=5","date":"2023-06-20","type":"pipeline","source":"BioPharma Dive","summary":"Attovia, a new California biotech, launches with plans to rethink how drugs bind their targets - BioPharma Dive","headline":"Attovia, a new California biotech, launches with plans to rethink how drugs bind their targets","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMingFBVV95cUxPVVFEbExSbjE5S0VsNTZtR3labGg1RWYxMWVpZHVDYlR5V29rNlpPRGxibldvQVVMRnhUX05EejdHN1VQYlFLcEJieTA2OXA0dzY3ZXBmeElwdWNqXzRSa1g1UzZuUzJUSFhNM0RCVnotMm00SmltSDgyOXN2ZlRGeVkxR1k4Q2xSYjhyU0pFdk9sVVpNdzhfVVRHdFhIUQ?oc=5","date":"2023-06-20","type":"pipeline","source":"Genetic Engineering and Biotechnology News","summary":"Small Nanobody Drug Developer Launches with $60M - Genetic Engineering and Biotechnology News","headline":"Small Nanobody Drug Developer Launches with $60M","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMioAJBVV95cUxPNnNKUXNXRHNJVE5FY3hWMHl0a0NCZDRTUHdUU3d2ZTk1amNqUDhwS3daTmxHUm9INEdHNlI2NmVWbXcwUlh0UjVBUDh5SmRfWlJEYURUQmF1cTdzb0NkU3J5Y1pCc1daZWRHVVVUTDIyakZKazhSdS1FRW9aYTZfSHMzM1UwejlxY2txcEpEdkJxZEQxbUFSR19fMFUydXBERXZGSjR6MWQxejNzUDlheTV4Nm9LbWMtS2JfTjJZQWpWZG0xTXNFMzNRV0NHY2MxYW9uVzRkdUluTzJKZTdxbnhsbmV5QXRFNFlLVnFCWThPZ2x6OGNXWWxGVGR4N2F5anhfNzE0cjRfdG9uUEk5Ul9fUGlUMVJEYk5tTFdUb08?oc=5","date":"2023-06-20","type":"pipeline","source":"GlobeNewswire","summary":"Attovia Therapeutics Launches with $60 Million Series A - GlobeNewswire","headline":"Attovia Therapeutics Launches with $60 Million Series A","sentiment":"neutral"}],"patents":[],"drugCount":2,"phaseCounts":{"phase_1":2},"enrichmentLevel":2,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}